VHCP Management’s Coherus Oncology CHRS Stock Holding History

VHCP Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8.6M	Hold	305,505	–	–	9.25%	3
2016 Q3	$8.18M	Sell	305,505 -305,505	-50%	-$8.33M	8.05%	3
2016 Q2	$10.3M	Hold	611,010	–	–	10.69%	3
2016 Q1	$13M	Hold	611,010	–	–	11.26%	3
2015 Q4	$14M	Sell	611,010 -259,259	-30%	-$6.67M	8.48%	5
2015 Q3	$17.4M	Hold	870,269	–	–	4.47%	6
2015 Q2	$25.2M	Hold	870,269	–	–	7.09%	5
2015 Q1	$26M	Hold	870,269	–	–	5.99%	6
2014 Q4	$13.1M	Buy	+870,269	New	+$12.3M	3.6%	9

Other funds holding CHRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VHCP Management's CHRS Position: Q4 2016 in Review

VHCP Management held its Coherus Oncology (CHRS) position steady in Q4 2016 at 305,505 shares worth $8.6M. The position accounts for 9.25% of the portfolio, ranked #3.

VHCP Management first reported a position in CHRS in Q4 2014 and has held it in 9 quarters since. The position peaked at $26M in Q1 2015. 122 funds tracked by Wall St. Rank hold CHRS as of Q4 2016.

VHCP Management held 305,505 shares of Coherus Oncology worth $8.6M as of Q4 2016.
VHCP Management left its Coherus Oncology share count unchanged in Q4 2016.
Coherus Oncology made up 9.25% of VHCP Management's portfolio in Q4 2016, its #3 holding.
VHCP Management first reported a position in Coherus Oncology in Q4 2014 and has held it in 9 quarters since.
VHCP Management's Coherus Oncology position peaked at $26M in Q1 2015.
122 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.